January 18, 2016
No known treatment has showed significant long-term remission that is strong enough to declare a Lupus patient as cured. That was, until now.
Today, biotech experts at the French medical research company, Neovacs, are on the brink of a true landmark medical breakthrough. At Neovacs, the focus is not on drug treatment. Instead, Neovacs believes in the therapeutic philosophy of the body’s own immunity. (In other words, enhancing the immunity of the patient to develop an adequate response to fight disease.) It is currently in the advanced clinical trial stage of a therapeutic injectable vaccine for Lupus whose clinical trial results have been nothing short of astounding: Complete remission of symptoms for years, no side effects, no secondary treatments needed, and best of all, a remarkably strong immune system.
Watch The Balancing Act and see why experts are saying a cure for Lupus is, quite iterally, imminent.
Bringing the best tips from the experts in Atlanta in business, beauty, wealth management, child healthcare, car shopping, and more. Each year, Atlanta’s Women’s Entrepreneurship Initiative selects 15 local female entrepreneurs for a 15-month business training program. We meet women who have grown their companies, created jobs, and broke through the glass ceiling. With some […]
iMCD is the deadliest subtype of Castleman disease. Approximately one third of patients die within five years of diagnosis, and another third die within 10 years if not treated.
There are no effective treatment options for people with unresectable or metastatic chondrosarcoma despite many attempts by multiple pharmaceutical companies over the past few decades.